Literature DB >> 10199243

An HIV-1-infected individual homozygous for the CCR-5 delta32 allele and the SDF-1 3'A allele.

H Kuipers, C Workman, W Dyer, A Geczy, J Sullivan, R Oelrichs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10199243     DOI： 10.1097/00002030-199902250-00025

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  21 in total

1.  R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.

Authors:  Becky Schweighardt; Ann-Marie Roy; Duncan A Meiklejohn; Edward J Grace; Walter J Moretto; Jonas J Heymann; Douglas F Nixon
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.

Authors:  Qingwen Jin; Lokesh Agrawal; L Meyer; R Tubiana; Ioannis Theodorou; Ghalib Alkhatib
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

3.  Counterpoint: Cord blood stem cell therapy for acquired immune deficiency syndrome.

Authors:  Ghalib Alkhatib
Journal:  Stem Cells Dev       Date:  2009 Jan-Feb       Impact factor: 3.272

4.  A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.

Authors:  Hassan M Naif; Anthony L Cunningham; Mohammed Alali; Shan Li; Najla Nasr; Marc M Buhler; Dominique Schols; Erik de Clercq; Graeme Stewart
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.

Authors:  Timothy J Henrich; Emily Hanhauser; Zixin Hu; Hans-Jürgen Stellbrink; Christian Noah; Jeffrey N Martin; Steven G Deeks; Daniel R Kuritzkes; Florencia Pereyra
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

6.  Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele.

Authors:  Lachlan Gray; Melissa J Churchill; Niamh Keane; Jasminka Sterjovski; Anne M Ellett; Damian F J Purcell; Pantelis Poumbourios; Chenda Kol; Bin Wang; Nitin K Saksena; Steven L Wesselingh; Patricia Price; Martyn French; Dana Gabuzda; Paul R Gorry
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.

Authors:  Silvana Tasca; Siu-Hong Ho; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

8.  Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.

Authors:  Paul R Gorry; Fahim Ahmad; Jon Mohl; Ghalib Alkhatib
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

9.  CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo.

Authors:  Lokesh Agrawal; Qingwen Jin; Jeff Altenburg; L Meyer; R Tubiana; Ioannis Theodorou; Ghalib Alkhatib
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 10.  The biology of CCR5 and CXCR4.

Authors:  Ghalib Alkhatib
Journal:  Curr Opin HIV AIDS       Date:  2009-03       Impact factor: 4.283
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.